2025
Time to metastasis after prostatectomy (TTM) and survival outcomes in patients (pts) with metachronous metastatic hormone-sensitive prostate cancer (mHSPC): A secondary analysis of the SWOG 1216 phase 3 trial.
Sayegh N, Jo Y, Swami U, Hage Chehade C, Ozay Z, Gebrael G, Maughan B, Plets M, Hussain M, Dorff T, Lara P, Goldkorn A, Lerner S, Agarwal N. Time to metastasis after prostatectomy (TTM) and survival outcomes in patients (pts) with metachronous metastatic hormone-sensitive prostate cancer (mHSPC): A secondary analysis of the SWOG 1216 phase 3 trial. Journal Of Clinical Oncology 2025, 43: 173-173. DOI: 10.1200/jco.2025.43.5_suppl.173.Peer-Reviewed Original ResearchAndrogen deprivation therapyProgression-free survivalOverall survivalMetachronous diseaseMetastatic hormone-sensitive prostate cancerInitial prostate cancer diagnosisTiming of metastatic diseaseHormone-sensitive prostate cancerSubgroups of ptsTime of prostatectomyTime to metastasisCox proportional hazards modelsProstate cancer diagnosisProportional hazards modelDeprivation therapyGleason scoreMetastatic diseaseMetastatic recurrenceMetastatic diagnosisPrognostic factorsPerformance statusProstate cancerPrognostic valueSurvival outcomesProstatectomyRadical prostatectomy is associated with favorable outcomes in patients over 80 years old.
Kim I, Leapman M, Kim M, Rahman S, Sprenkle P, Renzulli J, Brito J, Hyams E, Kim J, Pareek G, Kim I. Radical prostatectomy is associated with favorable outcomes in patients over 80 years old. American Journal Of Clinical And Experimental Urology 2025, 13: 33-42. PMID: 40124572, PMCID: PMC11928824, DOI: 10.62347/nkgs2301.Peer-Reviewed Original ResearchProstate cancer-specific survivalLocalized prostate cancerRadical prostatectomyProstate cancerPatients treated with radical prostatectomyAssociated with higher OSAssociated with favorable outcomesCancer-specific survivalTreated with radiotherapyMedian OSMedian PSAFavorable survivalMedian agePatient ageFavorable outcomeHigher OSRadiotherapySEER-17Cox regressionCompare survivalProstatectomyPatientsSurvivalCancerDiagnosis
2024
Association of Crowd-Sourced Assessment of Technical Skills and Outcomes of Robotic-assisted Radical Prostatectomy
Rabil M, Jalfon M, Heckscher D, Song Z, Li F, Martin T, Sprenkle P, Hesse D, Kim I, Leapman M, Cavallo J. Association of Crowd-Sourced Assessment of Technical Skills and Outcomes of Robotic-assisted Radical Prostatectomy. Urology 2024, 193: 87-94. PMID: 39019332, DOI: 10.1016/j.urology.2024.07.014.Peer-Reviewed Original ResearchRobotic-assisted laparoscopic prostatectomyCrowd-Sourced AssessmentGEARS scoreCrowd-sourced assessment of technical skillsRALP casesOutcomes of robot-assisted radical prostatectomyRobot-assisted radical prostatectomyExpert narrative reviewPelvic fluid collectionsPatient outcomesLikelihood of sepsisPost-operative outcomesAssociated with significant improvementsFellowship-trained urologistsAssessment of technical skillsRadical prostatectomyLaparoscopic prostatectomyAssociated with improvementsGlobal Evaluative AssessmentFluid collectionLogistic regression modelsSurgeon selectionPracticing surgeonsProstatectomySurgeons
2023
MR Imaging-Guided Prostate Cancer Therapies
Adamo D, Greenwood B, Ghanouni P, Arora S. MR Imaging-Guided Prostate Cancer Therapies. Radiologic Clinics Of North America 2023, 62: 121-133. PMID: 37973238, DOI: 10.1016/j.rcl.2023.06.012.Peer-Reviewed Original ResearchConceptsProstate cancerTransrectal high-intensity focused ultrasoundLong-term oncologic dataIntermediate-risk prostate cancerTreatment of prostate cancerWhole-gland therapyTransurethral ultrasound ablationRadical prostatectomyHigh-Intensity Focused UltrasoundRadiation therapyImaging-guided therapyTherapeutic optionsOncological dataUltrasound ablationCancerTherapyProstateTreatmentAblationMenProstatectomyCryoablationMalignancyUltrasoundManagement of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy
Hayden C, Rahman S, Lokeshwar S, Choksi A, Kim I. Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy. Current Oncology Reports 2023, 25: 729-734. PMID: 37071296, DOI: 10.1007/s11912-023-01420-6.Peer-Reviewed Original ResearchConceptsAdjuvant androgen deprivation therapyNode-positive prostate cancerStandard of careRadical prostatectomyRadiation therapyProstate cancerPathologic node-positive patientsAdjuvant radiation therapyAndrogen deprivation therapyNode-positive patientsSalvage radiation therapySubset of patientsRobust clinical trialsProstate cancer patientsRecent systematic reviewDeprivation therapyCause mortalityTreatment optionsCancer patientsClinical trialsPatientsControl groupSystematic reviewTherapyProstatectomyMP77-14 PATIENT AND FACILITY FACTORS ASSOCIATED WITH 90-DAY MORTALITY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER
Laditi F, Nie J, Marks V, Leapman M. MP77-14 PATIENT AND FACILITY FACTORS ASSOCIATED WITH 90-DAY MORTALITY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER. Journal Of Urology 2023, 209: e1107. DOI: 10.1097/ju.0000000000003351.14.Peer-Reviewed Original Research
2022
Comparison of perioperative complications for extended vs standard pelvic lymph node dissection in patients undergoing radical prostatectomy for prostate cancer: a meta-analysis.
Kong J, Lichtbroun B, Sterling J, Wang Y, Wang Q, Singer EA, Jang TL, Ghodoussipour S, Kim IY. Comparison of perioperative complications for extended vs standard pelvic lymph node dissection in patients undergoing radical prostatectomy for prostate cancer: a meta-analysis. American Journal Of Clinical And Experimental Urology 2022, 10: 73-81. PMID: 35528467, PMCID: PMC9077149.Peer-Reviewed Original ResearchPelvic lymph node dissectionLymph node dissectionRadical prostatectomyPerioperative complicationsRandom-effects modelProstate cancerSurgery subgroupNode dissectionComplication rateRisk ratioSubgroup analysisStandard pelvic lymph node dissectionTime of RPRobotic approachCochrane LibraryComplicationsSPLNDGreater riskPatientsAvailable evidencePooled dataAdditional studiesCancerSignificant differencesProstatectomy
2021
18F-Fluciclovine Uptake in a Ureterocele.
Bitar R, Szklaruk J, Martiniova L, Zurita A, Chery L, Ravizzini G. 18F-Fluciclovine Uptake in a Ureterocele. Clinical Nuclear Medicine 2021, 46: e3-e5. PMID: 32956112, DOI: 10.1097/rlu.0000000000003272.Peer-Reviewed Original ResearchConceptsPET/CT imagingBilateral pelvic lymph node dissectionSerum prostate-specific antigen levelPelvic lymph node dissectionProstate-specific antigen levelF-fluciclovine PET/CTPost radical prostatectomyLymph node dissectionRight ureterovesical junctionF-fluciclovineRadical prostatectomyNode dissectionAntigen levelsUreterovesical junctionProximal thighPET/CTIV administrationUreteroceleProstatectomyProstateMBqAbnormalitiesDissectionSerumPelvis
2020
Plasma, Prostate and Urine Levels of Tocopherols and Metabolites in Men after Supplementation with a γ-Tocopherol-Rich Vitamin E Mixture
Goodin S, Kim I, Lee M, Shih W, Orlick M, Zheng X, Yang C. Plasma, Prostate and Urine Levels of Tocopherols and Metabolites in Men after Supplementation with a γ-Tocopherol-Rich Vitamin E Mixture. Nutrition And Cancer 2020, 73: 2740-2750. PMID: 33319628, PMCID: PMC8670097, DOI: 10.1080/01635581.2020.1857412.Peer-Reviewed Original ResearchConceptsVitamin E mixtureProstate tissue levelsUrine samplesReported adverse eventsDay of surgeryProstate cancer patientsPhase 0 trialsDays of supplementationCancer preventive activityAdverse eventsBlood lossTreatment armsUrine levelsCancer patientsRadical prostatectomyAnimal modelsVitamin EProstate tissueTissue levelsPreventive activitiesProstate levelsSupplementationPatientsProstatectomySurgeryRadiation Dose to the Rectum With Definitive Radiation Therapy and Hydrogel Spacer Versus Postprostatectomy Radiation Therapy
Yang DX, Verma V, An Y, Yu JB, Sprenkle PC, Leapman MS, Park HS. Radiation Dose to the Rectum With Definitive Radiation Therapy and Hydrogel Spacer Versus Postprostatectomy Radiation Therapy. Advances In Radiation Oncology 2020, 5: 1225-1231. PMID: 33305083, PMCID: PMC7718530, DOI: 10.1016/j.adro.2020.08.015.Peer-Reviewed Original ResearchDefinitive radiation therapyPostoperative radiation therapyHydrogel spacerRadiation therapyRectal dosimetryProstate cancerGroup 1Rectal dose-volume parametersPostprostatectomy radiation therapyDose-volume parametersPostprostatectomy settingSurgical patientsPrimary managementRectal volumeDefinitive settingRadical prostatectomyRectal dosesGroup 2High riskPatientsLinear regression analysisProstatectomyMann-WhitneyTherapyCancer
2019
Outcomes for urologic oncology procedures: are there differences between academic and community hospitals?
Syed JS, Abello A, Nguyen J, Lee AJH, Desloges JJ, Leapman MS, Kenney PA. Outcomes for urologic oncology procedures: are there differences between academic and community hospitals? World Journal Of Urology 2019, 38: 1187-1193. PMID: 31420696, DOI: 10.1007/s00345-019-02902-8.Peer-Reviewed Original ResearchConceptsLength of stayCommunity hospitalAcademic hospitalReadmission ratesRadical cystectomyHospital-based outcomesDirect costsMean direct costUrologic oncology proceduresStudent's t-testCase mix indexIndex admissionVizient databaseRadical nephroureterectomyPartial cystectomySurgical treatmentUrologic malignanciesOncologic proceduresPartial nephrectomyCystectomyOncology proceduresAcademic centersHospitalProstatectomyStayVariation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer
Tan W, Krimphove M, Cole A, Marchese M, Berg S, Lipsitz S, Löppenberg B, Nabi J, Abdollah F, Choueiri T, Kibel A, Sooriakumaran P, Trinh Q. Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer. Clinical Genitourinary Cancer 2019, 17: e1060-e1068. PMID: 31303561, DOI: 10.1016/j.clgc.2019.06.008.Peer-Reviewed Original ResearchConceptsPositive surgical marginsFactors associated with positive surgical marginsPositive surgical margin statusPT2 prostate cancerRadical prostatectomyProstate cancerCancer-specific factorsSurgical approachMargin statusHigher hospital surgical volumeSurgical margin statusNational Cancer DatabaseHospital surgical volumeCancer-specific featuresPSM rateSurgical marginsCancer DatabaseImprove patient outcomesEvaluating patientsContribution of patientLogistic regression modelsSurgical volumeProstatectomyPatientsPatient-specificPD17-02 CLINICAL RISK BASED ASSOCIATIONS OF LYMPH NODE DISSECTION AND DETECTION YIELD AMONG MEN TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER
Abello* A, Sprenkle P, Kenney P, Leapman M. PD17-02 CLINICAL RISK BASED ASSOCIATIONS OF LYMPH NODE DISSECTION AND DETECTION YIELD AMONG MEN TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000555562.32224.0f.Peer-Reviewed Original ResearchMP54-09 PROSTATECTOMY IN MEN WITH CLINICALLY POSITIVE LYMPH NODES: COMPARING SURVIVAL IN HIGH RISK CN-, PATHOLOGICALY NEGATIVE NODES, AND PATHOLOGICALLY POSITIVE NODAL DISEASE
Ryan* S, Ghali F, Hansen M, Hayn M, Sammon J, Sarkar R, Murphy J, Kader A, Rose B. MP54-09 PROSTATECTOMY IN MEN WITH CLINICALLY POSITIVE LYMPH NODES: COMPARING SURVIVAL IN HIGH RISK CN-, PATHOLOGICALY NEGATIVE NODES, AND PATHOLOGICALLY POSITIVE NODAL DISEASE. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000556686.46954.87.Peer-Reviewed Original ResearchReply to Effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer: Do we have certainties today?
Jang T, Kim I, Scardino P, Eastham J. Reply to Effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer: Do we have certainties today? Cancer 2019, 125: 2318-2320. PMID: 30861093, DOI: 10.1002/cncr.32054.Peer-Reviewed Original Research222 Variation in positive surgical margin status following radical prostatectomy for pT2 prostate cancer
Tan W, Krimphove M, Cole A, Berg S, Marchese M, Lipsitz S, Loppenberg B, Nabi J, Abdollah F, Choueiri T, Kibel A, Sooriakumaran P, Trinh Q. 222 Variation in positive surgical margin status following radical prostatectomy for pT2 prostate cancer. European Urology Open Science 2019, 18: e294-e295. DOI: 10.1016/s1569-9056(19)30214-3.Peer-Reviewed Original Research
2018
Correlation of Prostate Cancer CHD1 Status with Response to Androgen Deprivation Therapy: a Pilot Study.
Tabakin A, Sadimin E, Tereshchenko I, Kareddula A, Stein M, Mayer T, Hirshfield K, Kim I, Tischfield J, DiPaola R, Singer E. Correlation of Prostate Cancer CHD1 Status with Response to Androgen Deprivation Therapy: a Pilot Study. Journal Of Genitourinary Disorders 2018, 2 PMID: 30714046, PMCID: PMC6358174.Peer-Reviewed Original ResearchMonths of ADTProstate cancerProstate-specific antigen (PSA) recurrenceSpecific antigen recurrenceAndrogen deprivation therapyAdditional larger studiesProstate cancer patientsLymph node tissueCHD1 deletionDeprivation therapySerum PSAAndrogen deprivationClinical outcomesCancer patientsImmunohistochemical stainsTissue microarrayNode tissueERG fusionLarger studyIndependent correlationTumor suppressor genePilot studyStrong associationPatientsProstatectomy
2017
Point: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy? Quality of Life is Better After Modern Radiotherapy Compared With Surgery.
Yu J, Hamstra D. Point: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy? Quality of Life is Better After Modern Radiotherapy Compared With Surgery. Oncology 2017, 31: 830-2, 835. PMID: 29179251.Peer-Reviewed Original ResearchManagement of Postradical Prostatectomy Urinary Incontinence: A Review
Radadia K, Farber N, Shinder B, Polotti C, Milas L, Tunuguntla H. Management of Postradical Prostatectomy Urinary Incontinence: A Review. Urology 2017, 113: 13-19. PMID: 29031841, DOI: 10.1016/j.urology.2017.09.025.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPelvic floor muscle trainingTransurethral bulking agentsArtificial urinary sphincterTreat overactive bladderPostprostatectomy urinary incontinenceQuality of life of patientsDetrusor hypocontractilityMale slingRadical prostatectomyStress incontinenceOveractive bladderSphincter incompetenceUrinary sphincterOverflow incontinenceUrinary incontinenceTreatment modalitiesLife of patientsEfficacious optionMuscle trainingIncontinenceSuccess ratePatientsTreatmentBulking agentsProstatectomyIncreasing rate of positive margins in men with high-risk prostate cancer undergoing radical prostatectomy
Lester-Coll N, Bledsoe T, Johnson S, Nath S, Yu J. Increasing rate of positive margins in men with high-risk prostate cancer undergoing radical prostatectomy. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: s96. DOI: 10.1016/j.ijrobp.2017.06.231.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply